Allison C. Hoffman Sells 1,238 Shares of Phreesia, Inc. (NYSE:PHR) Stock

Phreesia, Inc. (NYSE:PHR) General Counsel Allison C. Hoffman sold 1,238 shares of the company’s stock in a transaction dated Monday, April 15th. The shares were sold at an average price of $22.86, for a total transaction of $28,300.68. Following the sale, the general counsel now directly owns 135,621 shares of the company’s stock, valued at $3,100,296.06. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link.

Phreesia Trading Down 2.3 %

Shares of PHR opened at $22.62 on Friday. The firm’s 50 day moving average price is $24.40 and its 200 day moving average price is $21.26. The company has a quick ratio of 1.78, a current ratio of 1.78 and a debt-to-equity ratio of 0.02. Phreesia, Inc. has a twelve month low of $12.05 and a twelve month high of $34.98.

Phreesia (NYSE:PHR) last issued its quarterly earnings data on Thursday, March 14th. The company reported ($0.56) earnings per share for the quarter, beating the consensus estimate of ($0.58) by $0.02. The firm had revenue of $95.00 million for the quarter, compared to analyst estimates of $93.52 million. Phreesia had a negative net margin of 38.42% and a negative return on equity of 53.33%. The company’s revenue for the quarter was up 24.0% on a year-over-year basis. During the same quarter last year, the firm earned ($0.72) earnings per share. As a group, equities research analysts forecast that Phreesia, Inc. will post -1.48 EPS for the current year.

Hedge Funds Weigh In On Phreesia

Hedge funds and other institutional investors have recently added to or reduced their stakes in the business. International Assets Investment Management LLC raised its position in Phreesia by 1,987.3% during the fourth quarter. International Assets Investment Management LLC now owns 1,482 shares of the company’s stock valued at $34,000 after acquiring an additional 1,411 shares in the last quarter. Captrust Financial Advisors grew its holdings in Phreesia by 154.6% during the second quarter. Captrust Financial Advisors now owns 1,426 shares of the company’s stock valued at $36,000 after purchasing an additional 866 shares during the last quarter. Acadian Asset Management LLC acquired a new position in Phreesia during the first quarter valued at approximately $43,000. State of Wyoming grew its holdings in Phreesia by 34.6% during the second quarter. State of Wyoming now owns 1,918 shares of the company’s stock valued at $59,000 after purchasing an additional 493 shares during the last quarter. Finally, Tower Research Capital LLC TRC grew its holdings in Phreesia by 85.4% during the third quarter. Tower Research Capital LLC TRC now owns 3,137 shares of the company’s stock valued at $80,000 after purchasing an additional 1,445 shares during the last quarter. Institutional investors own 92.10% of the company’s stock.

Wall Street Analyst Weigh In

A number of analysts have commented on PHR shares. Needham & Company LLC reaffirmed a “buy” rating and set a $29.00 price objective on shares of Phreesia in a research note on Friday, March 15th. Truist Financial started coverage on shares of Phreesia in a research note on Monday, February 26th. They set a “buy” rating and a $35.00 price objective for the company. Barclays started coverage on shares of Phreesia in a research note on Wednesday, January 3rd. They set an “overweight” rating and a $29.00 price objective for the company. DA Davidson reaffirmed a “neutral” rating and set a $32.00 price objective on shares of Phreesia in a research note on Friday, March 15th. Finally, Canaccord Genuity Group increased their price target on shares of Phreesia from $36.00 to $37.00 and gave the stock a “buy” rating in a research report on Friday, March 15th. Two analysts have rated the stock with a hold rating and twelve have given a buy rating to the stock. According to MarketBeat, Phreesia currently has a consensus rating of “Moderate Buy” and an average price target of $31.62.

About Phreesia

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.